Novacyt S.A.
NVYTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20 | $12 | $21 | $96 |
| % Growth | 69.5% | -45% | -78% | – |
| Cost of Goods Sold | -$12 | $8 | $15 | $66 |
| Gross Profit | $32 | $4 | $6 | $30 |
| % Margin | 163.4% | 32.2% | 27.3% | 31% |
| R&D Expenses | $3 | $3 | $5 | $5 |
| G&A Expenses | $40 | $5 | $5 | $7 |
| SG&A Expenses | $42 | $6 | $10 | $14 |
| Sales & Mktg Exp. | $1 | $1 | $5 | $7 |
| Other Operating Expenses | $25 | $24 | $8 | $12 |
| Operating Expenses | $69 | $33 | $22 | $31 |
| Operating Income | -$37 | -$30 | -$17 | -$1 |
| % Margin | -190.2% | -254.9% | -78.9% | -1.4% |
| Other Income/Exp. Net | -$2 | $1 | $3 | -$2 |
| Pre-Tax Income | -$39 | -$29 | -$20 | -$10 |
| Tax Expense | -$1 | -$1 | $2 | -$0 |
| Net Income | -$42 | -$28 | -$22 | -$10 |
| % Margin | -212.7% | -244.3% | -105.5% | -10.2% |
| EPS | -0.59 | -0.4 | -0.31 | -0.14 |
| % Growth | -47.5% | -29% | -121.4% | – |
| EPS Diluted | -0.59 | -0.4 | -0.31 | -0.14 |
| Weighted Avg Shares Out | 71 | 71 | 71 | 71 |
| Weighted Avg Shares Out Dil | 71 | 71 | 71 | 71 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $1 | $1 | $0 |
| Interest Expense | $5 | $1 | $0 | $0 |
| Depreciation & Amortization | -$0 | $10 | $2 | $2 |
| EBITDA | -$34 | -$18 | -$12 | -$4 |
| % Margin | -174.8% | -157.6% | -55.5% | -4.4% |